Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.45 | N/A |
PEG Ratio (TTM) | 0.01 | N/A |
P/S Ratio (TTM) | 0.35 | N/A |
P/B Ratio (TTM) | 3.09 | N/A |
P/FCF Ratio (TTM) | -2.14 | N/A |
Price to 5YR AVG Earnings Ratio | -0.83 | N/A |
Price to 5YR AVG FCF Ratio | -1.29 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -41.73% | N/A |
ROE (TTM) | -98.21% | N/A |
Net Profit Margin (TTM) | -77.05% | N/A |
ROIC 5YR AVG | -19.28% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -33.43% | -50.88% | -64.13% |
Revenue | -7.07% | -12.32% | -10.34% |
Net Income | -36.99% | -66.00% | -73.35% |
Cash Flow | -547.74% | -101.00% | -47.20% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.85 | N/A |
Quick Ratio (TTM) | 0.37 | N/A |
D/E Ratio (TTM) | 0.05 | N/A |
Interest Coverage (TTM) | -3.47 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.34 | N/A |
Shares Outstanding Growth 5YR AVG | 8.65% | N/A |